|
|
SPOT ON
|
|
Who buys whom? When big pharma goes shopping …
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Endocarditis prophylaxis: from rule to exception
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
ACE inhibitors plus angiotensin II receptor antagonists: a reasonable combination?
Levothyroxine (e.g. EUTHYROX) in the morning or at night?
|
|
|
QUALITY CONTROL
|
|
Quality comparison of bisoprolol (CONCOR, generics) tablets as well as lisinopril (ACERBON, generics) tablets
|
|
|
IN BRIEF
|
|
Do proton pump inhibitors attenuate the effectiveness of acetylsalicylic acid?
Mefloquine (LARIAM) no longer for emergency self-treatment of malaria
EMA - oral preparations of the vasodilatator buflomedil (FUFEDIL, generics) should be withdrawn from the market
Umbrella brands: what is FENISTIL - an antiallergic, a corticoid, a virostatic or a medical device?
|
|
|
BEWARE! MISSINFORMATION
|
|
Freeloader: promotion of PERENTEROL
|
|
|
SIDE EFFECTS
|
|
Hearing impairment due to terbinafine (LAMISIL, generics)
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Allergy to indacaterol (ONBREZ BREEZHALER)
|
|
|
e a-t IN THE INTERNET
|
|
Company guide: information supplementing the spot-on story
|
|